Exploration of Targeted Anti-tumor Therapy

Open Access Mini Review

The evolving landscape of first-line and subsequent therapies in EGFR-mutated NSCLC: efficacy, resistance, and tolerability

Carminia Maria Della Corte ... Floriana Morgillo

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002370

DOI: https://doi.org/10.37349/etat.2026.1002370

Full Text PDF

188 11 0

Open Access Commentary

FDA 2025 Cancer Drug Approvals: targeted therapy dominates

Jan Trøst Jørgensen

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002369

DOI: https://doi.org/10.37349/etat.2026.1002369

This article belongs to the special issue Precision Oncology: Molecular Classification, Efficacy Prediction, and Treatment Decision-Making

Full Text PDF

277 11 0

Open Access Systematic Review

The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review

Serin Moghrabi ... Akram Al-Ibraheem

Published: April 27, 2026 Explor Target Antitumor Ther. 2026;7:1002368

DOI: https://doi.org/10.37349/etat.2026.1002368

Full Text PDF

119 7 0

Open Access Case Report

Solitary fibrous tumor of the lung: diagnostic challenges and surgical management

Vasileios Leivaditis ... Manfred Dahm

Published: April 21, 2026 Explor Target Antitumor Ther. 2026;7:1002367

DOI: https://doi.org/10.37349/etat.2026.1002367

Full Text PDF

158 16 0

Open Access Original Article

Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia

Sergey V. Orlov ... Evgeny N. Imyanitov

Published: April 16, 2026 Explor Target Antitumor Ther. 2026;7:1002366

DOI: https://doi.org/10.37349/etat.2026.1002366

Full Text PDF

468 19 0

Open Access Original Article

Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Yuki Oda ... Kiyohide Fujimoto

Published: April 13, 2026 Explor Target Antitumor Ther. 2026;7:1002365

DOI: https://doi.org/10.37349/etat.2026.1002365

Full Text PDF

653 15 0

Open Access Original Article

Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition

Maellis Payet-Desruisseaux ... Borhane Annabi

Published: March 30, 2026 Explor Target Antitumor Ther. 2026;7:1002364

DOI: https://doi.org/10.37349/etat.2026.1002364

This article belongs to the special issue Novel Precision Medicine Approaches to Brain Tumors (Primary and Metastatic)

Full Text PDF

704 20 0

Open Access Original Article

CHD4 and NOX4 expression in thyroid tumor tissues

Salma Fenniche ... Rabii Ameziane El Hassani

Published: March 25, 2026 Explor Target Antitumor Ther. 2026;7:1002363

DOI: https://doi.org/10.37349/etat.2026.1002363

Full Text PDF

746 28 0

Open Access Original Article

Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort

Mehrshad Alirezaei Farahani ... Marjan Mansourian

Published: March 20, 2026 Explor Target Antitumor Ther. 2026;7:1002362

DOI: https://doi.org/10.37349/etat.2026.1002362

Full Text PDF

981 21 0

Open Access Review

Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer

Ogochukwu O. Izuegbuna

Published: March 09, 2026 Explor Target Antitumor Ther. 2026;7:1002361

DOI: https://doi.org/10.37349/etat.2026.1002361

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1709 34 0

Open Access Systematic Review

Comparison of weekly docetaxel regimens in prostate cancer: a systematic review and frequentist network meta-analysis

Shree Rath ... Amar Lal

Published: February 27, 2026 Explor Target Antitumor Ther. 2026;7:1002360

DOI: https://doi.org/10.37349/etat.2026.1002360

Full Text PDF

1460 34 0

Open Access Mini Review

Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma

Pinelopi Samara ... Ioannis Athanasopoulos

Published: February 24, 2026 Explor Target Antitumor Ther. 2026;7:1002359

DOI: https://doi.org/10.37349/etat.2026.1002359

Full Text PDF

1370 33 0

Open Access Review

Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution

George Anderson

Published: February 13, 2026 Explor Target Antitumor Ther. 2026;7:1002358

DOI: https://doi.org/10.37349/etat.2026.1002358

Full Text PDF

1806 28 0

Open Access Perspective

Application of explainable artificial intelligence integrating with electronic health record in oncology

Yuhan Yang, Xici Liu

Published: February 04, 2026 Explor Target Antitumor Ther. 2026;7:1002357

DOI: https://doi.org/10.37349/etat.2026.1002357

Full Text PDF

2036 16 1

Open Access Editorial

The critical need for robust decision support in the era of precision cancer therapeutics

Maurie Markman

Published: January 22, 2026 Explor Target Antitumor Ther. 2026;7:1002356

DOI: https://doi.org/10.37349/etat.2026.1002356

Full Text PDF

964 41 0